In prostate cancer, GSK3 has been shown to inhibit androgen receptor-stimulated cell growth, whereas high expression levels of GSK3 have been shown to participate in NF-κB mediated cell survival in pancreatic cancer [29, 30]. Here, AR is linked to prostate carcinoma.